The global Verzenio market is showing robust growth, driven by the rising incidence of breast cancer and increasing adoption of targeted therapies. Verzenio (abemaciclib) has become a key treatment option for both early-stage and advanced or metastat...

Markdown supported · ⌘↵ to post
No responses yet.